Positive expression ratio in prostate cancer group (PCa) was 70.6% (48/68) and that in benign prostatic hyperplasia (BPH) group was 21.6% (16/74), suggesting that URG11 levels were significantly upregulated in prostate cancer tissues (p < 0.01). The gene discussed is VWCE; the disease is prostate cancer.